INHIBITION OF APOPTOSIS AND AUGMENTATION OF LYMPHOPROLIFERATION IN BCL-2 TRANSGENIC FAS FAS LIGAND-DEFECTIVE MICE/

Citation
A. Tamura et al., INHIBITION OF APOPTOSIS AND AUGMENTATION OF LYMPHOPROLIFERATION IN BCL-2 TRANSGENIC FAS FAS LIGAND-DEFECTIVE MICE/, Cellular immunology, 168(2), 1996, pp. 220-228
Citations number
34
Categorie Soggetti
Cell Biology",Immunology
Journal title
ISSN journal
00088749
Volume
168
Issue
2
Year of publication
1996
Pages
220 - 228
Database
ISI
SICI code
0008-8749(1996)168:2<220:IOAAAO>2.0.ZU;2-1
Abstract
Mice defective in Fas (CD95 or APO-1) or its ligand (lpr or gld mice) develop age-dependent lymphadenopathy and systemic autoimmune disease. T cells accumulating in the lymph nodes of these mice express reduced levels of Bcl-2 protein and are susceptible to spontaneous and glucoc orticoid-induced apoptosis, We backcrossed bcl-2 transgenic mice to lp r and gld mice to homozygosity to determine the effects of Bcl-2 overe xpression, T cells in these mice were resistant to spontaneous and glu cocorticoid-induced apoptosis in vitro, Moreover, the accumulation of CD4(-)CD8(-) T cells in the lymph nodes and the spleens was augmented, suggesting that a Bcl-2-dependent mechanism regulating the number of T cells residing in the peripheral lymphoid organs in addition to the Fas mediated pathway exists. (C) 1996 Academic Press, Inc.